CompoAtlas

時本美 鳳凰概念食品

時本美 鳳凰概念食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
TRANS-RESVERATROLTRANS-RESVERATROLNot identified
PIPERINEPIPERINEPipérine
D-SORBITOLD-SORBITOLNot identified
MICROCRYSTALLINE α-CELLULOSEMICROCRYSTALLINE α-CELLULOSENot identified
HYDROXYPROPYL CELLULOSEHYDROXYPROPYL CELLULOSENot identified
SILICON DIOXIDESILICON DIOXIDENot identified
CALCIUM STEARATECALCIUM STEARATENot identified
SHELLACSHELLACNot identified
CARNAUBA WAXCARNAUBA WAXNot identified
GELATINGELATINNot identified
GLYCEROLGLYCEROLGlycérol
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
TARTRAZINETARTRAZINENot identified
SUNSET YELLOW FCFSUNSET YELLOW FCFNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1139041151
Chinese name
時本美 鳳凰概念食品
English name
KIRAKIRA KINIRO
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
元嘉生醫股份有限公司
Registration date
2024-07-04
Published validity end
2029-07-04

Original register data

View published fields and their variants
Product name
時本美 鳳凰概念食品
Active ingredients
TRANS-RESVERATROL;;PIPERINE;;D-SORBITOL;;MICROCRYSTALLINE α-CELLULOSE;;HYDROXYPROPYL CELLULOSE;;SILICON DIOXIDE;;CALCIUM STEARATE;;SHELLAC;;CARNAUBA WAX;;GELATIN;;GLYCEROL;;TITANIUM DIOXIDE;;TARTRAZINE;;SUNSET YELLOW FCF;;
Valid until
1180704
Registration number
1139041151
Licence holder
元嘉生醫股份有限公司
Registration date
1130704
Published reference
DHC0B390411512
Published English name
KIRAKIRA KINIRO

Official source

View the official register, number 1139041151

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • PIPERINE
    Read the warning, when it applies and the studies cited

    BLACK/WHITE PEPPER - PIPER NIGRUM

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications or any other health products, as black/white pepper/piperine may alter their effectiveness (Han 2011; Srinivasan 2007; Khajuria et al. 2002; Bano et al. 1991).1

    Sources cited by Health Canada (4)
    • Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. European Journal of Pharmacology 1991;41(6):615-7. PubMed
    • Han HK. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opinion on Drug Metabolism & Toxicology 2011;7(6):721-729. PubMed Review article
    • Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002;9(3):224-31. PubMed
    • Srinivasan K. Black Pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition 2007;47(8):735-748. PubMed Review article

    1Note: At subtherapeutic quantities, the risk statement regarding the alteration of effectiveness is not required for products providing 25 mg or less Piper nigrum fruit per day for Class II and III applications.

    Condition of application: Improve digestion.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Vermifuge/anthelmintic.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or persist for more than 2 weeks.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line